OR WAIT null SECS
May 19, 2022
East Syracuse site will serve as a hub for company’s US biologics CDMO business
May 18, 2022
Should be administered at least five months after the second dose of the two-dose primary series
Deal establishes company’s presence in Mexico
May 17, 2022
It is the first solution that allows pharma and biotech to design, set up, plan, orchestrate, and scale APT supply chains with one single system, the company reports
May 16, 2022
Will be investing up to $100 million to expand presence in Taiwan
May 13, 2022
Company anticipating to double global network size by end of the year
May 12, 2022
Among functions, 80,000 square-foot space will house a 'Center of Excellence'
May 11, 2022
Location will feature aseptic fill-finish technology
May 10, 2022
Deal for PROPENSITY4 grows company’s data analytics knowledge
Pfizer to commercialize NURTEC® ODT, an innovative compound for the prevention and acute treatment of migraine